Provider review
Fifty 410 review
Prices tirzepatide by the tier and semaglutide not at all
Fifty 410's GLP-1 programme reads "Starting at $199/month" as its headline, and the only itemized figures on the page are tirzepatide's: $133/month billed as $399 for three months, and a high-dose tier at $183/month billed as $549 — no semaglutide-specific number appears anywhere on the site.
Straight talk: how we earn — some, not all, of these are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.
On this page
The verdict
Fifty 410 runs a genuinely low-friction, no-membership model — pay for what you order, no subscription, a fast 24-48 hour provider review, and a refund policy that is unusually generous for this category: "Before payment: Full Refund (100% refund, no questions asked)" and a full refund on unshipped medication even after payment, right up until compounding begins. Where it gets harder to compare is the price itself. The programme's own headline is "Starting at $199/month," a single figure covering both semaglutide and tirzepatide, and the only itemized dose table on the page belongs to tirzepatide alone — $133/month on a 3-month, $399 prepay, or $183/month on a 3-month, $549 prepay for a higher dose. A reader specifically comparing semaglutide costs has nothing itemized to check it against. The compounding pharmacy is described only as a category — "FDA-registered 503A and 503B compounding pharmacies" — not a named facility, and no state-coverage list is published.
Fifty 410 is not ranked on any of our boards. This is a standalone read of what the company publishes about itself — the providers we do rank in this category are on our semaglutide provider ranking. Nothing on this page is a performance claim — see the evidence review for what these compounds do and do not do.
Who it is for, and who it is not
A good fit if
- You want tirzepatide specifically — Fifty 410 itemizes two dose tiers for it, both as 3-month prepays
- You want a genuinely generous refund policy — full refund, no questions asked, before compounding begins
- You want no membership or subscription, paying only for what you order
Look elsewhere if
- You want a semaglutide-specific price to compare against other providers — none is published
- You want month-to-month billing rather than a 3-month prepay to reach the itemized rate
- You want a named compounding pharmacy rather than a regulatory category
What it actually costs
What they advertise
"Starting at $199/month" for the GLP-1 programme generally. Tirzepatide is itemized: $133/month billed as $399 for three months, and a high-dose tier at $183/month billed as $549 for three months.
What you actually pay, month to month
The tirzepatide figures are real, itemized, 3-month-prepay rates. No semaglutide-specific figure is published anywhere on the site — the $199 "starting at" headline is the only number that could apply to it, and it is not broken out by molecule or dose.
The commitment trap
"Starting at $199/month" reads as if it applies evenly to both molecules, but the only itemized dose table on the page is tirzepatide-only, billed as a 3-month prepay rather than month-to-month.
Money you will meet later
- No semaglutide-specific price is published — only a generic "starting at" figure
- The itemized tirzepatide rates require a 3-month, $399 or $549 prepay to reach
Checked live on Fifty 410's own site at https://fifty410.com/weight-loss in August 2026. Prices change without notice — confirm before you buy. Work out what a vial actually gives you with our peptide dose calculator.
What is included
The cheapest headline number in this category is often the one with the least attached to it. Here is what Fifty 410 bundles in, and what it does not.
Clinician consult
A licensed provider reviews the intake within 24-48 hours.
Bloodwork / labs
Not addressed in the sources read.
Follow-ups and dose changes
Not addressed with a specific cadence in the sources read.
Human support
Not itemized in the sources read.
Injection supplies
Not itemized in the sources read.
Shipping
Medication ships to the door; specific cost and timeframe not…
detailed in the sources read.
Pharmacy, labs and oversight
The pharmacy
Not named individually. Fifty 410 states medications are "compounded by FDA-registered 503A and 503B compounding pharmacies, which are subject to federal and state regulatory oversight" — a category, not a specific facility.
Oversight
A licensed provider reviews the intake within 24-48 hours. Not addressed with a specific cadence in the sources read.
Compounded peptides are not FDA-approved products, and a 503A pharmacy compounds for a named patient while a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Our guide to verifying a certificate of analysis covers what to ask for.
Where you can get it
Not published as a specific list.
The honest cons
The part they would rather you skipped
The refund policy is genuinely strong — full, no-questions-asked refunds before compounding — but the pricing that sits above it is asymmetric: tirzepatide gets an itemized dose table with real 3-month-prepay figures, while semaglutide gets only the same generic "Starting at $199/month" headline the whole programme shares. A reader who came specifically to price semaglutide has nothing itemized to check that number against.
- No semaglutide-specific price is published — only a generic "starting at" figure shared with tirzepatide
- The itemized tirzepatide rates are 3-month prepays, not a month-to-month option
- No compounding pharmacy named — only a regulatory category
- No published state-coverage list
- Compounded medications are not FDA-approved
None of this is unique to Fifty 410 — the whole category shares it. What we hold against a provider is the part it hides, and the ways vendors hide things are catalogued in our vendor red-flags guide.
How it compares
The providers we rank on our semaglutide provider ranking, in the order that board ranks them. Fifty 410 is not among them: it is reviewed here, not ranked there, and we would rather show you the comparison than pretend the two are the same thing.
- BHBodybuilding Health+One of the deepest peptide catalogues here, and the loosest one
- Enhance MDWrites a flat-price-at-every-dose policy down — and charges near the top for it
- RxSpan MDOral tablet only, at a real $179 monthly rate
- Direct MedsThe plainest price mechanics on either board, from a company with an FDA warning letter
- Synergy RxPublishes a starting number, and nothing about what it commits you to
- Sprout HealthA $150 markdown the site never explains, and a semaglutide price quoted by the quarter
- Strut HealthInjection or troche, but $119 is the auto-refill price only
- MadeMedPrices are published — but there is no monthly option at all
7 more providers rank on our semaglutide provider ranking — see the full ranking. Every provider we review →
Read this before you buy
A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.
Facts on this page reflect Fifty 410's own public disclosures when we last checked them, in August 2026. Prices and terms change without notice — confirm on Fifty 410's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.